ArticleClinical and experimental medicine2026
ITM2A promotes thyroid cancer differentiation through metabolic reprogramming and enhances PD-L1-dependent T-cell responses.
Wuhui Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.